Cell. 2019 Jan 24;176(3):581-596.e18.

Wheeler MA¹, Jaronen M¹, Covacu R¹, Zandee SEJ², Scalisi G¹, Rothhammer V¹, Tjon EC¹, Chao CC¹, Kenison JE¹, Blain M³, Rao VTS³, Hewson P¹, Barroso A¹, Gutiérrez-Vázquez C¹, Prat A², Antel JP³, Hauser R⁴, Quintana FJ⁵.

1. Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
2. Neuroimmunology Research Lab, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada.
3. Neuroimmunology Unit, Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
4. Department of Epidemiology and Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA; Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA.
5. Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: fquintana@bwh.harvard.edu.

Presented by Michael Wheeler